The activity of sSR-A in accelerating arthritis progression and Th17 inflammatory responses was also independently confirmed using a higher dose of SR-A protein (30 μg/mouse) (Supplementary Fig. 4). This evidence concerns the gene MSR1 and arthritic joint disease.